Vericel to Present at the 20th Annual Needham Growth Conference
January 10 2018 - 8:00AM
Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded
autologous cell therapies for the treatment of patients with
serious diseases and conditions, today announced that Nick
Colangelo, president and CEO, will present the latest company
overview at the 20th Annual Needham Growth Conference at the Lotte
New York Palace in New York City, NY on Thursday, January 18, 2018
at 8:40am Eastern time.
The presentation will be webcast live at
http://wsw.com/webcast/needham84/vcel/ and may be accessed from the
news and events section of the Vericel website.
About Vericel Corporation
Vericel develops, manufactures, and markets expanded autologous
cell therapies for the treatment of patients with serious diseases
and conditions. The company markets two cell therapy products in
the United States. Vericel is marketing MACI® (autologous cultured
chondrocytes on porcine collagen membrane), an autologous
cellularized scaffold product indicated for the repair of
symptomatic, single or multiple full-thickness cartilage defects of
the knee with or without bone involvement in adults. Vericel is
also marketing Epicel® (cultured epidermal autografts), a permanent
skin replacement for the treatment of patients with deep dermal or
full thickness burns greater than or equal to 30% of total body
surface area. For more information, please visit the company's
website at www.vcel.com.
Epicel® and MACI® are registered trademarks of Vericel
Corporation. © 2018 Vericel Corporation. All rights reserved.
Global Media Contacts:David SchullRusso
Partners LLC+1 212-845-4271 (office)+1 858-717-2310
(mobile)David.schull@russopartnersllc.com
Karen ChaseRusso Partners LLC+1 646-942-5627 (office)+1
917-547-0434 (mobile)Karen.chase@russopartnersllc.com
Investor Contacts:Chad RubinThe Trout
Groupcrubin@troutgroup.com+1 (646) 378-2947
Lee SternThe Trout Grouplstern@troutgroup.com+1 (646)
378-2922
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Apr 2023 to Apr 2024